Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

[1]  F. Fowkes.  Epidemiology of Peripheral Vascular Disease , 2011, Springer London.

[2]  T. Mueller,et al.  Serum total 8-iso-prostaglandin F2alpha: a new and independent predictor of peripheral arterial disease. , 2004, Journal of vascular surgery.

[3]  P. Fontana,et al.  The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case–control study , 2004, Journal of thrombosis and haemostasis : JTH.

[4]  R. Becker,et al.  Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. , 2003, American heart journal.

[5]  A. Castelnuovo,et al.  Homocysteine levels are associated with the severity of peripheral arterial disease in Type 2 diabetic patients , 2003, Journal of thrombosis and haemostasis : JTH.

[6]  A. Alexandrov,et al.  Carotid Artery Stenosis: Grayscale and Doppler Ultrasound Diagnosis—Society of Radiologists in Ultrasound Consensus Conference , 2003, Ultrasound quarterly.

[7]  R Eugene Zierler,et al.  Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. , 2003, Radiology.

[8]  Emile R Mohler,et al.  Peripheral arterial disease: identification and implications. , 2003, Archives of internal medicine.

[9]  Eric J Topol,et al.  Critical issues in peripheral arterial disease detection and management: a call to action. , 2003, Archives of internal medicine.

[10]  J. Kelton,et al.  Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System , 2003, Annals of Internal Medicine.

[11]  M. Kibbe,et al.  Can screening for genetic markers improve peripheral artery bypass patency? , 2002, Journal of vascular surgery.

[12]  N. Key,et al.  Hyperhomocyst(e)inemia and Thrombophilia. , 2002, Archives of pathology & laboratory medicine.

[13]  P. Ridker,et al.  Inflammatory bio‐markers and cardiovascular risk prediction , 2002, Journal of internal medicine.

[14]  J. Cardella,et al.  Position statement on the use of the ankle brachial index in the evaluation of patients with peripheral vascular disease. A consensus statement developed by the Standards Division of the Society of Interventional Radiology. , 2002, Journal of vascular and interventional radiology : JVIR.

[15]  J. Cardella,et al.  Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease: a consensus statement developed by the standards division of the society of cardiovascular & interventional radiology. , 2002, Journal of vascular and interventional radiology : JVIR.

[16]  K. Ouriel.  Peripheral arterial disease , 2001, The Lancet.

[17]  H. Stricker,et al.  Homocysteine, vitamins and gene mutations in peripheral arterial disease , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[18]  B. Lindblad,et al.  The impact of factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions. , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[19]  W. Hiatt,et al.  Medical treatment of peripheral arterial disease and claudication. , 2001, The New England journal of medicine.

[20]  S. Eichinger,et al.  Multiplexed mutagenically separated PCR: simultaneous single-tube detection of the factor V R506Q (G1691A), the prothrombin G20210A, and the methylenetetrahydrofolate reductase A223V (C677T) variants. , 2001, Clinical chemistry.

[21]  G. Lowe,et al.  Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study. , 2000, Atherosclerosis.

[22]  W. Herrmann,et al.  Plasma Homocysteine and Lipoprotein Profile in Patients with Peripheral Arterial Occlusive Disease , 2000, Angiology.

[23]  Angst,et al.  Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age , 1999, European journal of clinical investigation.

[24]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[25]  V. Armstrong,et al.  Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. , 1999, Clinical chemistry.

[26]  P. Reitsma,et al.  The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis. , 1998, Atherosclerosis.

[27]  B. Dahlbäck,et al.  Activated protein C resistance in patients with peripheral vascular disease. , 1998, Journal of vascular surgery.

[28]  C. Wittwer,et al.  Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. , 1997, Clinical chemistry.

[29]  R. Rutherford,et al.  Recommended standards for reports dealing with lower extremity ischemia: revised version. , 1997, Journal of vascular surgery.

[30]  R. Langer,et al.  The Epidemiology of Peripheral Arterial Disease: Importance of Identifying the Population at Risk , 1997, Vascular medicine.

[31]  G. Standen,et al.  Activated protein C resistance, factor V Leiden and peripheral vascular disease. , 1997, Cardiovascular surgery.

[32]  S E Humphries,et al.  Genetic determinants of arterial thrombosis. , 1994, Bailliere's best practice & research. Clinical haematology.

[33]  F. Fowkes,et al.  The Epidemiology of Peripheral Arterial Disease , 1993 .

[34]  J. Ja.  Epidemiology of peripheral vascular diseases , 1975 .

[35]  F. Rosendaal,et al.  Hypercoagulability: too many tests, too much conflicting data. , 2002, Hematology. American Society of Hematology. Education Program.

[36]  W. Renner,et al.  Factor II G20210A and Factor V G1691A Gene Mutations and Peripheral Arterial Occlusive Disease , 2000, Thrombosis and Haemostasis.

[37]  P. Bernard,et al.  Integrated amplification and detection of the C677T point mutation in the methylenetetrahydrofolate reductase gene by fluorescence resonance energy transfer and probe melting curves. , 1998, Analytical biochemistry.

[38]  T. Matsuo,et al.  [Activated protein C resistance]. , 1998, Ryoikibetsu shokogun shirizu.

[39]  R. Green,et al.  Activated protein C resistance: prevalence and implications in peripheral vascular disease. , 1996, Journal of vascular surgery.

[40]  R. Langer,et al.  Large Vessel and Isolated Small Vessel Disease , 1991 .

[41]  C. Ruckley.  Symptomatic and Asymptomatic Disease , 1991 .